Product Information
CETIRIZINE HCL 1 MG/ML SOLN is a generic product labeled by Apozeal Pharmaceuticals Inc., priced at $0.1199 per ML under NDC 83745018516. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Apr 27, 2009. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
Apozeal Pharmaceuticals Inc.NDC
83745018516
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078870FDA Approved
4/27/2009
TE Code
AA
On Market Since
12/20/2024
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 1 MG/ML SOLN has been published 54 times since Sep 24, 2025, and over the history we have for it it has declined 8.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1199 per ML |
|---|---|
| All-time high | $0.1441 (Jun 10, 2026) |
| All-time low | $0.1199 (Sep 23, 2026) |
| 52-week high | $0.1441 |
| 52-week low | $0.1199 |
| Median price | $0.1358 |
| Average price | $0.1360 |
| Largest weekly change | -16.3% (Sep 23, 2026) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 81% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apozeal Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine Hydrochloride Oral Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 1 MG/ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 1 MG/ML SOLN, manufactured by Apozeal Pharmaceuticals Inc., is $0.1199 per ML (NDC 83745018516), effective Sep 30, 2026.
How has the price of CETIRIZINE HCL 1 MG/ML SOLN changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 1 MG/ML SOLN has declined 8.6%. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 1 MG/ML SOLN?
Since Sep 24, 2025, the NADAC for CETIRIZINE HCL 1 MG/ML SOLN has ranged from a low of $0.1199 (Sep 23, 2026) to a high of $0.1441 (Jun 10, 2026), with a median of $0.1358 per ML.
Are there cheaper alternatives to CETIRIZINE HCL 1 MG/ML SOLN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CETIRIZINE HCL 1 MG/ML SOLN, is $0.0223 per ML — about 81% below CETIRIZINE HCL 1 MG/ML SOLN.
Who manufactures CETIRIZINE HCL 1 MG/ML SOLN?
CETIRIZINE HCL 1 MG/ML SOLN (NDC 83745018516) is labeled by Apozeal Pharmaceuticals Inc., and CMS classifies it as a generic product.